CIP2A antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | KIAA1524 (CIP2A) |
| Host | Mouse |
| Reactivity | Human, Rat |
| Recommended Dilution | WB: 1:1000 - 1:10000 |
| Clonality | monoclonal |
| Conjugation | Unconjugated |
| Isotype | IgG1 |
| Clone ID | 9H8 |
| Observed MW | 102 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | protein A+G purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, WB |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | Q8TCG1 |
| Gene ID | 57650 |
| Alias | Protein CIP2A,Cancerous inhibitor of PP2A,p90 autoantigen,CIP2A,KIAA1524 |
| Background | Antibody anti-CIP2A |
| Status | RUO |
| Note | Mol. Weight 102 kDa |
Descripción
Related Products
CIP2A antibody
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
Ver ProductoCIP2A antibody
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
Ver Producto
Protein CIP2A (CIP2A) Antibody
Protein CIP2A Antibody is a Rabbit Polyclonal against Protein CIP2A.
Ver Producto